Introduction
Vasculitis is an inflammatory disease with variable end-organ damage
that is classified based on involvement of small, medium or large
vessels.1 Leukocytoclastic vasculitis is a
small-vessel vasculitis predominantly affecting dermal capillaries and
venules, and often secondary to underlying systemic vasculitis,
infection or drug exposure.1 Commonly implicated drugs
include beta-lactam antibiotics and non-steroidal anti-inflammatory
drugs,1 while calcium channel blockers and
hydroxymethylglutaryl-coA reductase inhibitors (statins) have been
rarely associated2-6 – with no previous formal case
report for verapamil. We present a case of cutaneous leukocytoclastic
vasculitis associated with recently initiated verapamil and
atorvastatin.